Zejing Pharmaceutical (688266.SH) submitted an application for H-share issuance and listing to the Hong Kong Stock Exchange and published the application materials.

Financial app news: Zhejiang Jing Pharmaceutical (688266.SH) announced that on December 19, 2025, the company submitted an application to the Hong Kong Stock Exchange to issue H shares and list on the main board of the Hong Kong Stock Exchange. The application materials were published on the Hong Kong Stock Exchange website on the same day. The application materials were prepared and published by the company in accordance with the requirements of the Securities and Futures Commission of Hong Kong and the Hong Kong Stock Exchange. The information contained in the application materials may be updated and revised in a timely manner, and investors should not make any investment decisions based on the information provided.